Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms

<p>Abstract</p> <p>Background</p> <p>The objective of this exploratory analysis was to characterize efficacy and onset of action of a 3-month treatment period with risperidone long-acting injection (RLAI), adjunctive to an individual's treatment regimen, in subject...

Full description

Bibliographic Details
Main Authors: Haskins John T, Turkoz Ibrahim, Adler Caleb M, Macfadden Wayne, Turner Norris, Alphs Larry
Format: Article
Language:English
Published: BMC 2011-10-01
Series:BMC Psychiatry
Online Access:http://www.biomedcentral.com/1471-244X/11/171